Kyverna Therapeutics, Inc. KYTX Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Kyverna Therapeutics, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s total debt?
- Kyverna Therapeutics, Inc. (KYTX) reported total debt of $9.16M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s total debt changed year-over-year?
- Kyverna Therapeutics, Inc.'s total debt increased by 32.1% year-over-year, from $6.94M to $9.16M.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s total debt?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s total debt has grown at a -28.9% compound annual growth rate (CAGR), from $9.08M to $4.6M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.